Boston Scientific fills cardiovascular stent gap with Medinol's NIR technology.
This article was originally published in The Gray Sheet
Executive Summary
BOSTON SCIENTIFIC FINDS CARDIOVASCULAR STENT NIRVANA WITH MEDINOL PACT announced Nov. 13. The company gets exclusive rights to Medinol's NIR stent technology under the deal, giving it the missing piece needed to build a stent/angioplasty catheter combination.